SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurogen (NRGN)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
523 35 0 NRGN
Emcee:  Terry McCormick Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
248 There was little action in the options this week. The highest priced option waphbolton-1/27/2000
247 <i>...I also thought that the eyeglass post was inane as it contained zerDoc Bones-1/26/2000
246 Rick, <<He's also under intense pressure to repeat his '99 perfoMiljenko Zuanic-1/25/2000
245 >> I've never heard of the guy. << You should forgive Miljenkoscaram(o)uche-1/25/2000
244 <i>AIDD could offer a $100-200 mil in revenues over the next couple of yeThomas M.-1/25/2000
243 Thomas: As the other long term NRGN poster I also thought that the eyeglass pophbolton-1/25/2000
242 <i>The gentleman with the eyeglass specialist friend has a reputation forThomas M.-1/25/2000
241 I think he is hoping that you will see that when a quiet stock suddenly gets hoDoc Bones-1/25/2000
240 Neurogen Launches New Website for AIDD(TM) (Accelerated Intelligent Drug DiscovJim Oravetz-1/25/2000
239 Are you being a jerk for any particular reason? TomThomas M.-1/25/2000
238 When you are ready for prescription glasses let me know! Very good friend of myMiljenko Zuanic-1/24/2000
237 You mean an Internet strategy is not critical to a biotech company's succesThomas M.-1/24/2000
236 A lot of the biotechs are zooming, today seems to be one of NRGN's days. Iphbolton-1/24/2000
235 GOOD IDEAS WIN: Area biotech firm example of success Editor's note: This iJim Oravetz-12/9/1999
234 Thomas: That seems to be the case and it is unlike them to issue empty press rephbolton-12/3/1999
233 A whole lot of nothing in that press release. Tom Thomas M.-12/2/1999
232 NEUROGEN UPDATES STATUS OF PARTNERED DRUG DEVELOPMENT PROGRAMS PR Newswirephbolton-12/2/1999
231 Neurogen searching for science chief By Luther Turmelle BRANFORD ? The searJim Oravetz-12/2/1999
230 Neurogen to double staff By Edward J. Crowder New Haven Register BRANFORD — Jim Oravetz-11/11/1999
229 Thomas: You are probably right. Chiron is a good example. It had been languisphbolton-9/7/1999
228 This is a nice environment for biotech stocks, the best since '97. If NRGNThomas M.-8/26/1999
227 Neurogen Reports Second Quarter Financial Results PR Newswire - August 11, 19phbolton-8/12/1999
226 Neurogen (NRGN) Andrew H. and Thomas J. Tisch lifted their stake to 3,096,692 Thomas M.-7/24/1999
225 As ugly as it's been, many of the other hot neuro stocks have done worse siThomas M.-6/30/1999
224 < how NRGN got the WSJ to write such a prominent piece of fluff about the deLLCF-6/17/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News